Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer (NCT06963723) | Clinical Trial Compass
RecruitingNot Applicable
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
United States, Puerto Rico1,000 participantsStarted 2025-07-01
Plain-language summary
The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.
Who can participate
Age range21 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Minimum age of 21
✓. Understands English and/or Spanish
✓. Has a diagnosis of advanced/metastatic cancer
✓. Currently undergoing systemic therapy (enteral or parenteral) with non-curative intent
✓. Has been receiving treatment for at least 2 months
✓. Life expectancy of at least 6 months, in the opinion of the treating oncologist
✓. Cognitively able to give informed consent
Exclusion criteria
✕. Under the age of 21
✕. Does not understand English or Spanish
✕. Has cognitive deficits that would preclude understanding of consent form and/or questionnaires
✕. Undergoing treatment with curative intent (e.g., adjuvant chemotherapy for breast, lung, or ovarian cancer, primary curative therapy for testis cancer or lymphoma)